中 | EN

News & Trends

Home News & Trends Special Reports Back

Subject Recruitment Advertisement for Phase III Clinical Study of Therapeutic (Synthetic Peptide) Hepatitis B Vaccine (NHT210118)

Time：2021-12-09 02:44:03 hits：4600



Recommended reading

  • Novel Peptide Bioscience Co., Ltd. officially settles in Chongqing International Biological City

  • Novel Peptide Bioscience Co., Ltd. Officially Starts its Phase III Clinical Trial of Project NHT210118